Mahamaya Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 11, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	1.18	1.17	2.20	1.25	1.22
Debt / EBITDA Ratio	2.60	2.39	4.22	2.63	3.05
Net Debt / Equity Ratio	1.11	1.10	2.08	1.10	1.13
Net Debt / EBITDA Ratio	2.44	2.23	3.98	2.30	2.83
Net Debt / FCF Ratio	-4.97	-6.48	-2.07	-12.05	-16.08
Asset Turnover	-	1.76	1.70	2.05	-
Inventory Turnover	-	2.98	3.14	4.22	-
Quick Ratio	0.39	0.40	0.40	0.27	0.35
Current Ratio	1.19	1.19	1.12	1.13	1.11
Return on Equity (ROE)	-	34.53%	24.31%	21.34%	-
Return on Assets (ROA)	-	9.55%	7.89%	7.89%	-
Return on Invested Capital (ROIC)	15.95%	18.94%	14.82%	16.71%	11.93%
Return on Capital Employed (ROCE)	38.70%	40.50%	35.20%	27.90%	21.30%
Buyback Yield / Dilution	-	-23.62%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.